financetom
Business
financetom
/
Business
/
US FDA investigates death tied to Takeda's blood disorder drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA investigates death tied to Takeda's blood disorder drug
Nov 21, 2025 8:55 AM

Nov 21 (Reuters) - The U.S. Food and Drug Administration

is probing the death of a patient who developed harmful

antibodies after taking Takeda Pharmaceuticals' blood

disorder drug, the health regulator said on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Universal Q2 revenue up climbs on higher tobacco and ingredient sales volumes
Universal Q2 revenue up climbs on higher tobacco and ingredient sales volumes
Nov 5, 2025
Overview * Universal fiscal Q2 revenue up 6%, driven by higher tobacco and ingredient sales volumes * Operating income for fiscal Q2 down 2% due to unfavorable currency and higher write-downs * Net income for first half rises 64%, reflecting improved operational performance Outlook * Universal expects tobacco supply to move to oversupply by fiscal year-end * Company focuses on...
Heritage Insurance Q3 revenue beats estimates on higher new business premiums
Heritage Insurance Q3 revenue beats estimates on higher new business premiums
Nov 5, 2025
Overview * Heritage Q3 2025 revenue beats analyst expectations, net income rises significantly * Net combined ratio improved to 72.9%, indicating better underwriting performance * Company repurchased 106,135 shares, announces new $25 mln share repurchase plan Outlook * Heritage expects policy count to return to growth over the next six months Result Drivers * UNDERWRITING DISCIPLINE - Heritage attributes improved...
Lyft Q3 Swings to Profit, Revenue Increases
Lyft Q3 Swings to Profit, Revenue Increases
Nov 5, 2025
05:42 PM EST, 11/05/2025 (MT Newswires) -- Lyft ( LYFT ) reported Q3 net income late Wednesday of $0.11 per diluted share, swinging from a loss of $0.03 a year earlier. Analysts polled by FactSet expected earnings of $0.08. Revenue for the quarter ended Sept. 30 was $1.69 billion, up from $1.52 billion a year earlier. Analysts expected $1.70 billion....
Stoneridge Q3 sales falls
Stoneridge Q3 sales falls
Nov 5, 2025
Overview * Stoneridge Q3 sales of $210.3 mln down from $213.8 mln, net loss of $9.4 mln * Company updates full-year revenue guidance to low end due to production volume reductions * Stoneridge announces new program awards totaling over $185 mln lifetime revenue Outlook * Stoneridge updates full-year 2025 revenue guidance to $860 mln - $870 mln * Company revises...
Copyright 2023-2026 - www.financetom.com All Rights Reserved